Latest Marketing Strategy News

Lynch Group Holdings delivered solid FY25 results with revenue growth led by Australian supermarket floral demand and strong Chinese tulip exports, while FY26 outlook signals mixed conditions.

Cleo Diagnostics has launched a health economic study in partnership with EntityRisk and Norstella to support the U.S. market entry of its Ovarian Cancer Pre-Surgical Test, aiming to refine reimbursement strategies and accelerate commercialisation.

Articore Group Limited reported a notable turnaround in FY25 with improved margins and its first profitable quarter in five years, setting the stage for positive EBIT in FY26. The company’s strategic restructuring and supply chain efficiencies underpin cautious optimism for growth.

Articore Group reported an 11% decline in FY25 revenue to $438.6 million, with net losses widening to $11.3 million despite margin improvements from operational restructuring. The company aims for a profitable turnaround in FY26 under new leadership.

Findi Limited has raised $9.5 million through secured loan notes to accelerate its BC Maxx rollout with the Central Bank of India and expand its Brown Label ATM fleet. The funding comes with attractive investor options, signaling confidence in Findi’s growth trajectory.

HeraMED advances AI-driven maternity care partnerships and strengthens its US commercial team, navigating policy uncertainties while progressing its global expansion and funding strategies.

Osteopore Limited has won tender bids to supply its innovative orthopaedic implants to two major public hospitals in Vietnam, marking a significant step in its Asia Pacific expansion.

Beach Energy has reported a robust FY25 performance marked by significant production growth, record free cash flow, and strategic progress on key projects like the Waitsia Gas Plant and Moomba CCS. The company’s disciplined cost management and gas marketing strategy underpin a confident outlook for FY26.

Aeris Resources has secured gold hedges covering half of its FY26 Cracow production at a forward price of A$5,145.75 per ounce, aiming to stabilise revenue amid market fluctuations.

Advanced Health Intelligence Ltd has secured up to AUD 5.5 million from Oakley Capital Partners to support its ASX reinstatement and global growth ambitions, while targeting an additional USD 6 million from strategic investors and unlocking AUD 3 million in R&D grants.

Ovanti Limited has appointed Peter Maher, a seasoned BNPL executive from Zip Co, to lead its US expansion, while exploring a NASDAQ listing via dual-listing or SPAC merger and reconsidering the sale of a key dividend-yielding asset.

Cardiex reported strong growth in its Pulse arterial health monitor sales during Q4 FY25, surpassing A$0.7 million for the year and advancing its transition to subscription-based digital health services.